Favipiravir for treating COVID-19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Favipiravir for treating COVID-19

Published:2024-02-05 Issue:2 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Korula Pritish¹,Alexander Hanna²,John Jisha Sara²,Kirubakaran Richard²,Singh Bhagteshwar³,Tharyan Prathap⁴,Rupali Priscilla²

Affiliation:

1. Division of Critical Care Medicine; Christian Medical College; Vellore India

2. Department of Infectious Diseases; Christian Medical College; Vellore India

3. Institute of Infection, Veterinary and Ecological Sciences; University of Liverpool; Liverpool UK

4. Clinical Epidemiology Unit, Prof. BV Moses Centre for Evidence-Informed Healthcare and Health Policy; Christian Medical College; Vellore India

Publisher

Wiley

Reference110 articles.

1. Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease;AlQahtani;Scientific Reports,2022

2. New possibilities for targeted antiviral therapy for COVID-19: results of a multicenter clinical trial of the efficacy and safety of areplivir;Balykova;Infectious Diseases,2020

3. Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicenter, placebo-controlled clinical trial;Bosaeed;Clinical Microbiology and infection,2022

4. Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial;Bosaeed;Clinical Microbiology and Infection,2022

5. Favipiravir versus arbidol for clinical recovery rate in moderate and severe adult COVID-19 patients: a prospective, multicenter, open-label, randomized controlled clinical trial;Chen;Frontiers in Pharmacology,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral replication organelles: the highly complex and programmed replication machinery;Frontiers in Microbiology;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3